— McCormick & Company Incorporated (NYSE: MKC) reported Q1 2020 earnings of $1.08 per share, vs. $1.03 expected.
— Sales fell 2% to $1.21 billion, vs. $1.23 billion expected.
— Consumer segment sales dropped 6% year-over-year to $699.5 million.
— Flavor Solutions segment sales grew 5% to $512.5 million.
— McCormick withdrew its FY2020 guidance due to the COVID-19 outbreak. The company expects to resume its guidance at the time of its Q2 results in June.
— MKC shares were up slightly in premarket hours on Tuesday.
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on
Comments